| Authors: |
Lozinski M; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.; Drug Repurposing and Medicines Research Program, Hunter Medical Research Institute, New Lambton, NSW, Australia.; Mark Hughes Foundation Centre for Brain Cancer Research, University of Newcastle, NSW, Australia., Bowden NA; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.; Drug Repurposing and Medicines Research Program, Hunter Medical Research Institute, New Lambton, NSW, Australia., Graves MC; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.; Drug Repurposing and Medicines Research Program, Hunter Medical Research Institute, New Lambton, NSW, Australia.; Mark Hughes Foundation Centre for Brain Cancer Research, University of Newcastle, NSW, Australia., Fay M; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.; Drug Repurposing and Medicines Research Program, Hunter Medical Research Institute, New Lambton, NSW, Australia.; Mark Hughes Foundation Centre for Brain Cancer Research, University of Newcastle, NSW, Australia.; GenesisCare, Newcastle, NSW, Australia., Day BW; QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Stringer BW; Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, Australia., Tooney PA; School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, NSW, Australia.; Drug Repurposing and Medicines Research Program, Hunter Medical Research Institute, New Lambton, NSW, Australia.; Mark Hughes Foundation Centre for Brain Cancer Research, University of Newcastle, NSW, Australia. |
